drugset / Trial / NCT02816567

Laparoscopic Surgery and Abdominal Compliance

NCT02816567

Phase 4 Unknown 180 enrolled Reims University Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of the study is to describe factors influencing abdominal compliance during laparoscopic surgery, including neuromuscular blocking agents (NMBA). The use of NMBA is randomized and blinded from the surgeons and the anesthesiologist. The abdominal compliance is measured by pressure/volume relationship.

Timeline

Start
2016-01
Primary completion
2018-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisatracurium Small molecule 0.06 mg/kg
Subject Cisatracurium Small molecule 0.12 mg/kg
Background Propofol Small molecule 6 ug/ml
Background Sufentanil Other / unclassified 0.4 ng/ml

Indications

No indication recorded.